News

Pharmabiz16h
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
Pharmabiz12h
Veranova appoints Thomas Rohrer as vice president of bioconjugation
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
Pharmabiz12h
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...
Pharmabiz14h
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
Pharmabiz10h
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis: Bologna Wednesday, July 30, 2025, 18:0 ...
Pharmabiz10h
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss: Our Bureau, Bengaluru Wednesday, July 30, 2025, 17:45 Hrs [IST] Physicians Committ ...
Pharmabiz11h
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify: Our Bureau, Mumbai Wednesday, July 30, 2025, 16:50 Hrs [IST] Rockwell Automatio ...
Pharmabiz13h
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease: Laval, Quebec Wednesday, July 30, 2025, 1 ...
Pharmabiz10h
SPPSPTM hosts Orientation Programme 2025 to welcome future pharma professionals
SPPSPTM hosts Orientation Programme 2025 to welcome future pharma professionals: Our Bureau, Mumbai Wednesday, July 30, 2025, 17:30 Hrs [IST] The induction programme 2025 for new ...
Pharmabiz13h
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Pharmabiz17h
Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT
Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT: Our Bureau, Bengaluru Wednesday, July 30, 2025, 10:45 Hrs [IST] Strides Pharma Sc ...
Pharmabiz18h
Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1
Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Wednesday, July 30, 2025, 10:00 Hrs [IST] A ...